International Parkinson and Movement Disorder Society COVID-19 Vaccine Statement

The International Parkinson and Movement Disorder Society leadership and its Scientific Issues Committee (MDS-SIC) has released a statement providing information regarding the COVID-19 vaccination opportunities, and particularly regarding patients with Parkinson’s Disease.

Notable points include:

  • The approved mRNA-based vaccines and the vector vaccines under development induce immunization through mechanisms that do not interact with the neurodegenerative process in PD.

  • The reported Phase III data of the approved vaccines showed that the types or incidence of side effects in patients with PD have not been different than in the general population.

  • Similar to reactions to other immunizations, COVID-19 vaccination does not interfere with the current therapies of PD.

  • As some of our patients may be part of the first groups in the current vaccination programs because of their age, residency in nursing homes, or other reasons related to PD disabilities, more data will be available in the near future for further analysis of the impact of these vaccines on PD.

For more information and the full statement from the International Parkinson and Movement Disorder Society, please click here.

PPRI